TrialThoracic cancer2021

Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma.

Kageaki Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.